IL

iX Life

Europe, Ile-de-France, France, Marly-le-roi

Description

iX Life is an investment firm

Investor Profile

iX Life has backed more than 3 startups, with 1 new investments in the last 12 months alone. The firm has led 3 rounds, about 100% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Seed rounds (top funding stages).
  • Majority of deals are located in France, Switzerland.
  • Strong thematic focus on Biotechnology, Medical, Health Care.
  • Led 1 rounds in the past year.

Stage Focus

  • Seed (100%)

Country Focus

  • France (67%)
  • Switzerland (33%)

Industry Focus

  • Biotechnology
  • Medical
  • Health Care
  • Health Diagnostics
  • Medical Device
  • Life Science
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does iX Life frequently co-invest with?

W
Europe, Ile-de-France, France, Paris
Co-Investments: 1
Angels Santé
Europe, Ile-de-France, France, Puteaux
Co-Investments: 1
Key Ventures
Europe, Ile-de-France, France, Paris
Co-Investments: 1
BA
Europe, Bretagne, France, Rennes
Co-Investments: 1
LB
Europe, Ile-de-France, France, Paris
Co-Investments: 1
A
North America, New York, United States, Scarsdale
Co-Investments: 1

What are some of recent deals done by iX Life?

SeaBeLife

Roscoff, Bretagne, France

SeaBeLife is a biotechnology company that develops a range of drug candidates.

BiotechnologyMedical
SeedOct 1, 2025
Amount Raised: $2,351,475
Quidditas Therapeutics

Montlhéry, Bretagne, France

Quidditas Therapeutics develops an alternative technology which permits an absolute genetic recombination.

BiotechnologyLife Science
SeedMay 12, 2025
Amount Raised: $1,010,895
SeaBeLife

Roscoff, Bretagne, France

SeaBeLife is a biotechnology company that develops a range of drug candidates.

BiotechnologyMedical
SeedSep 26, 2023
Amount Raised: $1,268,298
ATANIS Biotech

Oberkirch, Luzern, Switzerland

ATANIS Biotech engages in clinical allergy research and diagnostic assay development.

BiotechnologyHealth CareHealth DiagnosticsMedicalMedical Device
SeedMar 28, 2023